Skip to main content

Table 3 Repeated Measures Testing

From: A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study

 

Effect of Time

Effect of Treatment on Time

PDSS

  

   All Subjects

F (9,40) = 3.71; p = 0.002

F (9, 40) = 1.11; p = 0.10

   Low Ham-D group1

F (9,14) = 2.69; p = 0.047

F (9,14) = 2.01; p = 0.12

   High Ham-D group2

F (9,16) = 1.98; p = 0.11

F (9,16) = 0.22; p = 0.99

PDSS q1

  

   All Subjects

F (8,44) = 4.42; p < 0.001

F (8,44) = 1.41; p = 0.22

   Low Ham-D group1

F (8,17) = 2.34; p < 0.067

F (8,17) = 1.85; p = 0.14

   High Ham-D group2

F (8,18) = 1.75; p = 0.15

F (8,18) = 0.45; p = 0.87

PDSS q2

  

   All Subjects

F (8,44) = 5.16; p < 0.001

F (8,44) = 1.25; p = 0.29

   Low Ham-D group1

F (8,18) = 5.19; p < 0.002

F (8,18) = 0.85; p = 0.57

   High Ham-D group2

F (9,18) = 2.3; p = 0.064

F (9,18) = 1.36; p = 0.28

Ham-A

  

   All Subjects

F (8,43) = 8.81; p < 0.001

F (8,43) = 1.90; p = 0.077

   Low Ham-D group1

F (9,15) = 4.24; p = 0.007

F (9,15) = 1.96; p = 0.12

   High Ham-D group2

F (9,18) = 5.05; p = 0.002

F (9,18) = 0.75; p = 0.66

SPAS-p

  

   All Subjects

F (9,41) = 0.80; p = 0.62

F (9,41) = 0.57; p = 0.82

Ham-D

  

   All Subjects

F (9,43) = 4.30; p < 0.001

F (9,43) = 1.17; p = 0.33

  1. Outcome measures tested by a General Linear Model Repeated Measures analysis. Testing was initially done for all subjects together, and then for subjects grouped into high or low Ham-D groups based on initial Ham-D scores.
  2. 1 – Subset of patients with Ham-D scores < 27
  3. 2 – Subset of patients with Ham-D scores ≥ 27